Melissa Hodeib
Overview
Explore the profile of Melissa Hodeib including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee A, Ayoub N, Xu L, Cannavale K, Gilfillan A, Szamreta E, et al.
Cancer Manag Res
. 2025 Feb;
17:281-291.
PMID: 39963550
Purpose: Evidence on the impact of the coronavirus disease 2019 (COVID-19) pandemic on outcomes in patients with ovarian cancer patients is limited. We compared remission outcomes in patients with ovarian...
2.
Mukherjee A, Shammas N, Xu L, Cannavale K, Gilfillan A, Szamreta E, et al.
Front Oncol
. 2024 Apr;
14:1290719.
PMID: 38601762
Introduction: The Coronavirus Disease 2019 (COVID-19) pandemic posed critical challenges in providing care to ovarian cancer (OC) patients, including delays in OC diagnosis and treatment initiation. To accommodate for delays...
3.
Chao C, Cannizzaro N, Hahn E, Tewari D, Ngo-Metzger Q, Hsu C, et al.
Contemp Clin Trials
. 2022 Nov;
124:106994.
PMID: 36336248
Background: Limited guidance exists regarding implementation strategies that best facilitate cancer screening practice substitution and achieve optimal stakeholder-centered outcomes. Here we describe the protocol for a randomized pragmatic trial comparing...
4.
Shammas N, Yang T, Abidi A, Amneus M, Hodeib M
Gynecol Oncol Rep
. 2022 Jul;
42:101044.
PMID: 35866178
Uterine leiomyosarcoma (uLMS) is an aggressive mesenchymal tumor associated with a poor prognosis. Research demonstrates that PARP inhibitors (PARPi) improve disease-stable survival in patients with somatic mutations through the process...
5.
Hahn E, Munoz-Plaza C, Altman D, Hsu C, Cannizzaro N, Ngo-Metzger Q, et al.
Implement Sci Commun
. 2021 Sep;
2(1):108.
PMID: 34556189
Background: New cervical cancer screening guidelines recommend primary human papillomavirus (HPV) testing for women age 30-65 years. Healthcare organizations are preparing to de-implement the previous recommended strategies of Pap testing...
6.
Miller M, Xu L, Qin J, Hahn E, Ngo-Metzger Q, Mittman B, et al.
MMWR Morb Mortal Wkly Rep
. 2021 Jan;
70(4):109-113.
PMID: 33507893
On March 19, 2020, the governor of California issued a statewide stay-at-home order to contain the spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).* The order reduced...
7.
Nguyen M, Carter M, Zhao Z, Abidi A, Hodeib M
Case Rep Obstet Gynecol
. 2020 Jun;
2020:6473630.
PMID: 32566338
Solid pseudopapillary tumors are rare, with the majority of described cases originating in the pancreas. To date, there are only 10 documented reports of primary ovarian solid pseudopapillary tumors. Here,...
8.
Kinne N, Hodeib M, Kashani N, Tewari D
Obstet Gynecol
. 2019 Jul;
134(2):424.
PMID: 31348218
No abstract available.
9.
Wield A, Hodeib M, Khan M, Gubernick L, Li A, Kandukuri S
Gynecol Oncol Rep
. 2018 Sep;
26:37-40.
PMID: 30225334
Sebaceous carcinomas are rare tumors, with the majority of described cases occurring within the eyelid. To date, there are nine documented reports of sebaceous carcinoma arising within a mature cystic...
10.
Hodeib M, P Ogrodzinski M, Vergnes L, Reue K, Karlan B, Lunt S, et al.
Oncotarget
. 2018 Feb;
9(3):4044-4060.
PMID: 29423103
Metformin is a widely used agent for the treatment of diabetes and infertility, however, it has been found to have anti-cancer effects in a variety of malignancies including high grade...